Steven Porter, MD
InterMune
5
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Joel Moss, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Jidong Jia, MD
Beijing Friendship Hospital
Shared therapeutic areas:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Junqi Niu, MD
The First Hospital of Jilin University
Shared therapeutic areas:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Qing Xie, MD
Ruijin Hospital
Shared therapeutic areas:
Jesse Roman, MD
Emory University
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Rémi Rabasa-Lhoret
Institut de Recherches Cliniques de Montreal
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
All 5 trials loaded